JT has commented a few times that the company has not yet been forced to make a decision on partnering in EU. But now that the EU marketing application has been submitted, the clock is ticking IMO.
So two questions:
1) A partner or buyout is needed to commercialize V in EU. GIA is not an option. So does anyone have any thoughts on a possible time frame where/when a decision would need to be made? I’m thinking within next 3-6 months, but that’s just a guess.
2) Did Amarin intentionally delay the EU submission by 9 months in order to buy more time/defer this decision? In the meantime they also gained FDA approval, which essentially derisks the EU submission, as EU will most certainly follow FDA’s lead and approve V.
Would be curious to hear others thoughts. Happy holidays everyone.
Market Data 
Markets 
AI
